The therapeutic frontier for congenital adrenal hyperplasia stands at a critical juncture where scientific ambition meets clinical pragmatism, creating opportunities for transformative patient care while highlighting the persistent challenges of rare disease drug development. This complex endocrine disorder continues to inspire innovative research approaches while demanding...